|
MEMBER'S
PAPER
|
|
A Pazirandeh and M E Fazilat1 Physics
Department, University of Tehran email:
paziran@chamran.ut.ac.ir ABSTRACT
In Boron Neutron Capture Therapy, neutron and gamma dose determination is of prime importance. The neutron and gamma absorbed doses were measured in a cylindrical head phantom, 18cm in diameter and 20cm in height. For this purpose gold foils (bare and cadmium covered) and TLD-700 were used for neutron flux and gamma dose measurements respectively. The contributions to absorbed dose were due to 10B(n,a)7Li, 1H(n,g)2D, 14N(n,p)14C and recoil proton reactions. The KERMA factors for different energy groups were used to convert the neutron flux to the relevant absorbed dose. There was good agreement between experimental values and the calculated dose. INTRODUCTION Pioneering work of boron neutron capture therapy (BNCT) as a potential, clinical technique to destroy malignant tumors - especially glioblastoma- is usually attributed to two individuals: William H. Sweet and Hiroshi Hatanaka. Their work started in the early 1950s. In this technique, a neutron beam from a research reactor core passing through a proper moderator and a filter reduce the core neutron energy to epithermal range and a collimator converts them to an epithermal neutron beam. Prior to neutron bombardment, the patient is administered a boron-10 compound such as BSH (Na12B12 H11 SH). Then the epithermal neutron beam impinges on the patient head. The epithermal neutron beam is normally used for deep-seated brain tumors since the epithermal neutrons are more or less slowed down and turn to thermal neutrons before reaching the tumor. It is worth mentioning that, because of its anti-body properties, BSH overwhelms the tumor. BSH is a stable and non-toxic compound.1 Therefore it can be applied without hesitation. The neutrons during passage through the brain undergo several reactions including 10B(n,a)7Li, 1H(n,g)2D, 14N(n,p)14C and elastic scattering from protons. Because the cross section for 10B(n,a)7Li reaction is rather high,3838 barns, Boron is very suitable for tumor therapy. In this reaction 2.79 MeV is released in the form of kinetic energy of two ions, 7Li and 4He, in a proportion reciprocal to their atomic masses. It should be pointed out that in 94% of reactions, a gamma ray with 478KeV is emitted. The energy of the alpha particles released in this reaction is enough to travel about 10mm in tissue. Therefore, each alpha particle because of its high LET can destroy a cancer cell. Because of the high Boron-10 concentration in the tumor, 40-50ppm, as compared to 10ppm in other parts of the brain, the absorbed dose due to this reaction in the tumor is several times higher than that in normal tissue. This is enhanced by the peak thermal neutron flux in the tumor. Fig. 1 Collimator and Al-Fe filter detailed design To determine the central beam hole axis, a radiographic cassette containing an x-ray film was placed in front of the beam hole, once with a gadolinium converter and second time without a converter. The irradiation period extended 24 hours. The x-ray film was scanned by a laser-scanner to determine the center of the neutron beam. The leakage neutron spectrum was measured at the beam outlet using an He-3 counter and the unfolding technique3,4. The spectrum from a bare Cf-252 neutron source, a distribution of well thermalized neutrons and the BNCT beam port neutron spectrum are shown in Fig. 2.
The dose measurements were carried out in a cylindrical head phantom made of Plexiglas, filled with distilled water. Bare and cadmium covered gold foils, 1cm diameter and 5mm, were used in three radial rows to measure thermal and epicadmium fluxes. The irradiated gold foils were counted on a HPGe detector. The absolute net area under the prominent Au-198 photo-peak, 412Kev was determined utilizing a detector efficiency factor. Using the following relations, thermal and epithermal neutron fluxes were determined.5
where
Fig.3 shows thermal and epicadmium fluxes along three lines inside the head phantom.
For gamma ray dose measurements the TLD-700s, 4mm in diameter and 1.5mm thick were used. The TLDs were calibrated prior to irradiation. DOSE
DETERMINATION
Major reactions in BNCT treatment are due to 10B(n,a)7Li, 14N(n,p)14C , 1H(n,g)2D, recoil protons and (n,n’) reactions. The absorbed dose in brain is as a result of thermal and epithermal neutron reactions as follows: 1. 10B(n,a)7Li reaction 10B + n à a + 7Li +2.79Mev 6% 10B + n à a + 7Li +2.31Mev 94%
7Li à
g
+ 0.478 Mev 2.
14N(n,p)14C
reaction 14N + n à p + 14C + 0.62Mev In this reaction 0.580 Mev energy is given off as kinetic energy of the proton and the remaining 40Kev, is taken away by 14C as kinetic energy. 3. 1H(n,g)2D reaction. Following neutron capture by a hydrogen nucleus, a 2.25 Mev gamma ray is emitted. Due to the high proportion of hydrogen in the brain, absorbed dose of this reaction is rather high. TLD-700 chips measured the absorbed dose of gamma rays of these reactions and core gamma rays. Ten TLD-700 chips were used in two radial rows. They were irradiated for 24 hours in the head phantom. Table 1 shows measured dose along the path to the small cylinder in the phantom. 4. Recoil proton and (n,n’) reactions. The determination of absorbed dose of epithermal neutrons is rather complicated. Scattering of epithermal neutrons from hydrogen nuclei resulted in proton recoil or elastic scattering. To estimate the absorbed dose due to these two reactions, the slowing down neutron spectrum was determined pointwise using the transport equation with anisotropic scattering.
The KERMA factor for ith group, Fn (Ei) was calculated using the following relation8:
Fn(Ei)
= 1.602*10-8 sN
m-1Etr (4) where
The incident epithermal neutrons on the human head phantom, undergo elastic scattering from hydrogen nuclei which may lead to recoil protons. As a result, the neutron spectrum extends to the thermal region as they travel towards the small cylinder tumor inside the phantom. RESULTS AND DISCUSSIONS
ACKNOWLEDGEMENT Thanks are due to Tehran Research Reactor (TRR) operating staff in cooperating during implementation of the project and thanks to Neutron Physics Group, specially H.Ghods and H. Zandi, for assisting radiography and foil activation analysis measurements. Table 1 Absorbed Dose of Gamma-rays, mrad/hr
Table 2 Absorbed
dose due to different reactions along central axis (RBE-mrad/hr)
REFERENCES 1.
Soloway A.H., Alarn F., Barth R.F., Anisuzzaman A.K.M. and Bapat
B.V. Tumor Targeting Agents for
Neutron Capture Therapy, Basic Life Science, Vol. 54, 1990. 2.
Caswell R.S and Coyne J.J., KERMA
factor for neutron energies below 30Mev, Radiation Research Vol. 83,
1980. 3. Marashi
M.K., Investigation and production
on an epithermal neutron\beam for boron neutron capture therapy,
Ph.D thesis, Physics Faculty,
Amir Kabir University, 1993, (supervisor 4.
Matzke Manfred, Unfolding of Pulse Height
Spectra, The HEPRO Program System, 5.
Khanbabaii Sh., Unfolding
of Neutron Field Spectrum using HEPRO CODES, Physics Department,
University of Tehran 1999, (supervisor Ali Pazirandeh). 6.
Beckurts K.H., Wirtz K., Neutron Physics, Springer-Verlag, 1964. 7.
Marashi M.K., Maiorino, J.R., Mendonca A.G., Santos A., IRAN-LIB
(Improved Range of ANISN/PC Library), A P3 Coupled Neutron Gamma Cross
Section Library in ISOTXS foramat to be used by ANISN/PC, CCC-0514/02),
Ann. Nucl. Energy, Vol. 18, No. 10, 597-602, 1991. 8.
Rogus R.D. , Harling
O.K. Yanch J.C.,(1994) Mixed field
dosimetry of epithermal neutron for boron capture therapy at the MTR-II
research reactor, Med. Phys. 21(10), October 1994. 9.
Raaijimakers C.P.J. and Konijnenberg M.W., (1995) Determination
of dose components in phantoms irradiated with an epithermal neutron
beam for boron neutron capture therapy, Med. Phys. 22(3), March
1995. Further study: Wheeler
F.J. and Nigg W., Three dimensional radiation distribution analysis for boron capture
therapy, Nuc.Sci and Eng., 110(1992) 16-31, 1992 Brugger
R.M. , Shin J-L. A. and H.B. Liu, An
epithermal neutron beam for
neutron capture therapy at the Missouri University Research Reactor, Nuclear
Technology, 98, June 1992. Barthy
R.F., Soloway A.H., and Fairchild R.G., Boron
neutron capture therapy for cancerCancer 7 0,12(1992) December 1992. Khan
Faizm, The Physics of Radiotherapy; |
| Previous | Home Page | Next |